JURA BioJURA Bio
JURA.Bio is a pioneering biotechnology company that combines AI and synthetic biology to develop next-generation genomic medicines and immune-based therapies. The company focuses on the discovery and development of novel TCR (T-cell receptor) therapies targeting the TCR-epitope-HLA synapse, a critical biological target for personalized medicine and immunotherapy.
Key features and capabilities include:
  • End-to-End Discovery Platform: JURA.Bio’s platform integrates generative machine learning and synthetic biology to design, build, and test new therapeutic molecules at scale.
  • Large-Scale TCR Library: The company has developed a library of over 100 billion human TCR candidates, enabling the discovery of antigen-specific TCRs for various diseases, including prostate cancer and other neoantigen targets.
  • Predictive Modeling: JURA.Bio uses advanced machine learning models to predict complex molecular interactions, accelerating the development of safe and effective therapies.
  • Applications in Oncology and Autoimmunity: The platform is designed to address challenging targets in cancer and autoimmune diseases, with a focus on developing therapies that are both effective and safe.
JURA.Bio’s innovative approach is ideal for applications in personalized medicine, cancer immunotherapy, and the development of novel genomic medicines.

数据评估

JURA Bio浏览人数已经达到14,如你需要查询该站的相关权重信息,可以点击"5118数据""爱站数据""Chinaz数据"进入;以目前的网站数据参考,建议大家请以爱站数据为准,更多网站价值评估因素如:JURA Bio的访问速度、搜索引擎收录以及索引量、用户体验等;当然要评估一个站的价值,最主要还是需要根据您自身的需求以及需要,一些确切的数据则需要找JURA Bio的站长进行洽谈提供。如该站的IP、PV、跳出率等!

关于JURA Bio特别声明

本站AI产品库AIProductHub提供的JURA Bio都来源于网络,不保证外部链接的准确性和完整性,同时,对于该外部链接的指向,不由AI产品库AIProductHub实际控制,在2024年12月13日 下午3:38收录时,该网页上的内容,都属于合规合法,后期网页的内容如出现违规,可以直接联系网站管理员进行删除,AI产品库AIProductHub不承担任何责任。

相关导航

暂无评论

none
暂无评论...